Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 16769779.
- Also identified by PMC identifier 1798207.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
It remains to be seen whether rituximab can live up to the high expectations and offer a more effective treatment for patients with AASV
Medical subject headings
- Antibodies, Antineutrophil Cytoplasmic
- Antibodies, Monoclonal
- Immunologic Factors
- Vasculitis